Captrust Financial Advisors Sutro Biopharma, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$3.41 - $8.95 $951 - $2,497	-279 Reduced 69.92%	120 $1,000
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $2,652 - $5,220	341 Added 587.93%	399 $3,000
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $216 - $285	-12 Reduced 17.14%	58 $1,000
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $1,420 - $1,927	70 New	70 $2,000

132

63.1M

205K

28.1K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $93.4M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.